{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T17:10:11Z","timestamp":1726247411400},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,1,7]],"date-time":"2002-01-07T00:00:00Z","timestamp":1010361600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1186\/1468-6708-3-2","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical significance of cardiovascular dysmetabolic syndrome"],"prefix":"10.1186","volume":"3","author":[{"given":"Prakash C","family":"Deedwania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,1,7]]},"reference":[{"key":"97_CR1","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1016\/S0002-9343(98)00204-6","volume":"105","author":"PC Deedwania","year":"1998","unstructured":"Deedwania PC: The deadly quartet revisited. Am J Med. 1998, 105: 1S-3S. 10.1016\/S0002-9343(98)00204-6.","journal-title":"Am J Med"},{"key":"97_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339: 229-234. 10.1056\/NEJM199807233390404.","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"97_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(97)90020-9","volume":"350","author":"PZ Zimmet","year":"1997","unstructured":"Zimmet PZ, Alberti KGMM: The changing face of macrovascular disease in non-insulin-dependent diabetes mellitus: an epidemic in progress. Lancet. 1997, 350 (suppl 1): 1-4.","journal-title":"Lancet"},{"issue":"suppl 1","key":"97_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(97)90026-X","volume":"350","author":"RC Eastman","year":"1997","unstructured":"Eastman RC, Keen H: The impact of cardiovascular disease on people with diabetes: the potential for prevention. Lancet. 1997, 350 (suppl 1): 29-32.","journal-title":"Lancet"},{"key":"97_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/diacare.18.2.258","volume":"18","author":"R Klein","year":"1995","unstructured":"Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995, 18: 258-268.","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"97_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0140-6736(97)90021-0","volume":"350","author":"DM Nathan","year":"1997","unstructured":"Nathan DM, Meigs J, Singer DE: The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it?. Lancet. 1997, 350 (suppl 1): 4-9.","journal-title":"Lancet"},{"issue":"suppl 11","key":"97_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/00005344-199200111-00002","volume":"20","author":"RA DeFronzo","year":"1992","unstructured":"DeFronzo RA: Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol. 1992, 20 (suppl 11): S1-S16.","journal-title":"J Cardiovasc Pharmacol"},{"key":"97_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1056\/NEJM199604113341504","volume":"334","author":"J-P DesPres","year":"1996","unstructured":"DesPres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996, 334: 952-957. 10.1056\/NEJM199604113341504.","journal-title":"N Engl J Med"},{"key":"97_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.7326\/0003-4819-125-4-199608150-00009","volume":"125","author":"E Grossman","year":"1996","unstructured":"Grossman E, Messerli FH: Diabetic and hypertensive heart disease. Ann Intern Med. 1996, 125: 304-310.","journal-title":"Ann Intern Med"},{"key":"97_CR10","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0002-9149(99)80326-9","volume":"76","author":"BC Solymoss","year":"1995","unstructured":"Solymoss BC, Marcil M, Chaour M, Gilfix BM, Poitras AM, Campeau L: Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women. Am J Cardiol. 1995, 76: 1152-1156. 10.1016\/S0002-9149(99)80326-9.","journal-title":"Am J Cardiol"},{"issue":"suppl 1A","key":"97_CR11","doi-asserted-by":"publisher","first-page":"4S","DOI":"10.1016\/S0002-9343(98)00205-8","volume":"105","author":"WA Hseuh","year":"1998","unstructured":"Hseuh WA, Law RE: Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am J Med. 1998, 105 (suppl 1A): 4S-14S. 10.1016\/S0002-9343(98)00205-8.","journal-title":"Am J Med"},{"key":"97_CR12","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM: Role of insulin resistance in human disease. Diabetes. 1988, 37: 1595-1607.","journal-title":"Diabetes"},{"issue":"suppl 1A","key":"97_CR13","doi-asserted-by":"publisher","first-page":"77S","DOI":"10.1016\/S0002-9343(98)00216-2","volume":"105","author":"TC Fagan","year":"1998","unstructured":"Fagan TC, Deedwania PC: The cardiovascular dysmetabolic syndrome. Am J Med. 1998, 105 (suppl 1A): 77S-82S. 10.1016\/S0002-9343(98)00216-2.","journal-title":"Am J Med"},{"issue":"suppl 1A","key":"97_CR14","doi-asserted-by":"publisher","first-page":"15S","DOI":"10.1016\/S0002-9343(98)00206-X","volume":"105","author":"AL Peters","year":"1998","unstructured":"Peters AL, Schriger DL: The new diagnostic criteria for diabetes: the impact on management of diabetes and macrovascular risk factors. Am J Med. 1998, 105 (suppl 1A): 15S-19S. 10.1016\/S0002-9343(98)00206-X.","journal-title":"Am J Med"},{"key":"97_CR15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","volume":"20","author":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"1997","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Commission on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997, 20: 1183-1197.","journal-title":"Diabetes Care"},{"key":"97_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2125.1990.tb03789.x","volume":"30","author":"PH Joubert","year":"1990","unstructured":"Joubert PH, Venter HL, Foukardis GN: The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?. Br J Clin Pharmacol. 1990, 30: 391-396.","journal-title":"Br J Clin Pharmacol"},{"key":"97_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1056\/NEJM199508313330903","volume":"333","author":"M Stumvoll","year":"1995","unstructured":"Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE: Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995, 333: 550-554. 10.1056\/NEJM199508313330903.","journal-title":"N Engl J Med"},{"key":"97_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1445-5994.1978.tb04524.x","volume":"8","author":"PJ Phillips","year":"1978","unstructured":"Phillips PJ, Scicchitano R, Clarkson AR, Gilmore HR: Metformin associated lactic acidosis. Aust NZ J Med. 1978, 8: 281-284.","journal-title":"Aust NZ J Med"},{"key":"97_CR19","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/0026-0495(95)90092-6","volume":"44","author":"TP Ciraldi","year":"1995","unstructured":"Ciraldi TP, Huber-Knudsen K, Hickman M, Olefsky JM: Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents. Metabolism. 1995, 44: 976-982.","journal-title":"Metabolism"},{"key":"97_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/0026-0495(95)90056-X","volume":"44","author":"T Fijuwara","year":"1995","unstructured":"Fijuwara T, Okuno A, Yoshioka S: Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL\/KsJ-db\/db mice. Metabolism. 1995, 44: 486-490.","journal-title":"Metabolism"},{"key":"97_CR21","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1172\/JCI118991","volume":"98","author":"RE Law","year":"1996","unstructured":"Law RE, Meehan WP, Xi XP, Graf K, Wuthrich DA, Coats W, Faxon D, Hsueh WA: Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest. 1996, 98: 1897-1905.","journal-title":"J Clin Invest"},{"key":"97_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2337\/diab.46.3.433","volume":"46","author":"MN Ghazzi","year":"1997","unstructured":"Ghazzi MN, Perez JE, Antonucci TK, Driscoll JH, Huang SM, Faja BW, The Troglitazone Study Group, Whitcomb RW: Cardiac and glycemic benefits of troglitazone treatment in NIDDM. Diabetes. 1997, 46: 433-439.","journal-title":"Diabetes"},{"key":"97_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0889-8529(05)70267-X","volume":"26","author":"RR Henry","year":"1997","unstructured":"Henry RR: Thiazolidinediones. Endocrinol Met Clin North Am. 1997, 26: 553-573.","journal-title":"Endocrinol Met Clin North Am"},{"key":"97_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/diacare.15.2.193","volume":"15","author":"SL Suter","year":"1992","unstructured":"Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM: Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care. 1992, 15: 193-203.","journal-title":"Diabetes Care"}],"container-title":["Current Controlled Trials in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-3-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1468-6708-3-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-3-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1468-6708-3-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:15:48Z","timestamp":1726244148000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1468-6708-3-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["97"],"URL":"https:\/\/doi.org\/10.1186\/1468-6708-3-2","relation":{},"ISSN":["1468-6708","1468-6694"],"issn-type":[{"type":"print","value":"1468-6708"},{"type":"electronic","value":"1468-6694"}],"subject":[],"published":{"date-parts":[[2002,1,7]]},"assertion":[{"value":"15 May 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}